Skip to main content
(352) 733-0111

JXR CARD MISS ALT FLOW

  • Status
    Accepting Candidates
  • Age
    18 Years - N/A
  • Sexes
    All
  • Healthy Volunteers
    No
I'm interested
Share this study
Facebook
Twitter
LinkedIn

Objective

The purpose of this study is to evaluate initial clinical safety, device functionality and effectiveness of the Edwards Transcatheter Atrial Shunt System.

Description

The early feasibility study of the Edwards Transcatheter Atrial Shunt System is a multi-center, prospective, early feasibility study to evaluate initial clinical safety, device functionality, and effectiveness of the Edwards Transcatheter Atrial Shunt System.

Details

Full study title Early Feasibility Study of the Edwards Transcatheter Atrial Shunt System
Protocol number OCR49036
ClinicalTrials.gov ID NCT03523416
Phase N/A

Eligibility

Inclusion Criteria:

  • Symptomatic Heart Failure (HF):

    • NYHA class II with a history of > II; III; or ambulatory IV AND

    • ≥ 1 HF hospital admission; or treatment with IV or oral diuresis within 12 months; OR an NT-pro BNP value > 150 pg./ml in normal sinus rhythm, > 450 pg./ml in atrial fibrillation, or a BNP value > 50 pg./ml in normal sinus rhythm, > 150 pg./ml in atrial fibrillation within the past 6 months prior to study entry.

  • On stable Guideline Directed Medical Therapy (GDMT) for heart failure

  • At rest: elevated LAP (or PCWP) of > 15 mmHg and LAP (or PCWP) exceeds right atrial pressure (RAP) by > 5 mmHg AND/OR supine ergometer exercise, elevated LA (or PCWP) pressure of > 25 mmHg and LA (or PCWP) exceeds right atrial pressure (RAP) by > 10 mmHg

  • Left Ventricular Ejection Fraction (LVEF) ≤ 40%

  • Pulmonary Vascular Resistance (PVR) < 4.0 WU

Exclusion Criteria:

  • Severe HF:

    • Stage D, non-ambulatory NYHA Class IV, transplant list

    • If BMI < 30, Cardiac index < 2.0 L/min/m2

    • If BMI ≥ 30, cardiac index < 1.8 L/min/m2

    • Left Ventricular End-Diastolic Diameter (LVEDD) > 8 cm

    • LVEF < 20%

  • Valve disease: MR > 3+ or > moderate MS, TR > 2+, AR > 2+ or > moderate AS

  • MI or therapeutic invasive cardiac procedure < 3 months

  • TIA, stroke, CRT implanted < 6 months

  • RV dysfunction > mild by TTE OR TAPSE < 1.2 OR RV size ≥ LV size by TTE, OR right ventricular fractional area change (RVFAC) ≤ 25%

  • Dialysis OR renal dysfunction (S-CR > 2.5 mg/dl OR eGFR < 25 ml/min/1.73m2)

  • 6MWT < 50m OR > 600m

  • Active endocarditis or infection < 3 months

  • Mean Right Atrial Pressure (mRAP) > 15 mmHg at rest

  • Body Mass Index (BMI) ≥ 45 kg/m2

Lead researcher

  • Dominick J Angiolillo, MD, PhD
    Cardiologist (Heart Specialist), Interventional Cardiologist
    Languages: Spanish, Italian

Participate in a study

Here are some general steps to consider when participating in a research study:

  1. Step
    1

    Contact the research team

    Call or email the research team listed within the specific clinical trial or study to let them know that you're interested. A member of the research team, such as the researcher or study coordinator, will be available to tell you more about the study and to answer any questions or concerns you may have.

    Primary contact

  2. Step
    2

    Get screened to confirm eligibility

    You may be asked to take part in prescreening to make sure you are eligible for a study. The prescreening process ensures it is safe for you to participate. During the prescreening process, you will be asked some questions and you may also be asked to schedule tests or procedures to confirm your eligibility.

  3. Step
    3

    Provide your consent to participate

    If you are eligible and want to join the clinical trial or study, a member of the research team will ask for your consent to participate. To give consent, you will be asked to read and sign a consent form for the study. This consent form explains the study's purpose, procedures, risks, benefits and provides other important information, such as the study team's contact information.

  4. Step
    4

    Participate

    If you decide to participate in a clinical trial or study, the research team will keep you informed of the study requirements and what you will need to do to throughout the study. For some trials or studies, your health care provider may work with the research team to ensure there are no conflicts with other medications or treatments.